Loading…
Screening for hypertension-mediated organ damage and aetiology: still of value after 65 years of age?
Secondary forms and hypertension-mediated organ damage (HMOD) may differ between younger and older hypertensive patients. The aim of the present study was to explore the specificity of HMOD and secondary forms in patients ≥ 65 years in comparison to younger ones in a contemporary cohort. We analysed...
Saved in:
Published in: | Journal of geriatric cardiology : JGC 2022-11, Vol.19 (11), p.791-801 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Secondary forms and hypertension-mediated organ damage (HMOD) may differ between younger and older hypertensive patients. The aim of the present study was to explore the specificity of HMOD and secondary forms in patients ≥ 65 years in comparison to younger ones in a contemporary cohort.
We analysed 938 patients recruited between 2004 and 2014 (Cardiology department, Croix-Rousse Hospital, Lyon) who had at baseline HMOD and secondary forms screening among them 190 were ≥ 65 years.
The mean (2.1 ± 0.8
1.2 ± 0.9,
< 0.001) and frequency of HMOD (96.3%
. 72.9%,
0.001) was higher in patients ≥ 65 years than younger ones. Carotid femoral pulse wave velocity > 10 m/s was the most frequent HMOD in patients ≥ 65 years (90.1%), while echocardiographic left ventricular hypertrophy was the most common in the younger patients (45.0%). Among ECG left ventricular indexes, only R wave in aVL lead was significantly more frequently observed in patients ≥ 65 years (32.6%) than in younger ones (19.0%,
0.001). The frequency of secondary hypertension was not significantly different between younger and older patients (respectively; 30.5%
27.8%,
= 0.487). The most frequent aetiology was primary aldosteronism regardless of age, followed by renovascular hypertension (6.3%
3.3%,
= 0.038). Among older patients, 3.2% were treated with adrenalectomy and 6.3% with percutaneous transluminal renal angioplasty.
Extensive screening of HMOD in older patients may be questionable as nearly all patients had one; aetiology must however be explored as a third of older patients had a secondary form. |
---|---|
ISSN: | 1671-5411 |
DOI: | 10.11909/j.issn.1671-5411.2022.11.005 |